Results 81 to 90 of about 3,083,119 (212)

Should People With a History of Psychosis Be Included in Psychedelic Research?

open access: yesCanadian Journal of Bioethics
The exclusion of all patients with a personal or family history of psychosis from psychedelic therapy research is a significant ethical concern. Beginning with a summary of the historical entanglement and disentanglement of psychedelic and psychosis ...
Khaleel Rajwani
doaj   +1 more source

‘So many relationships in the room’: Participant perspectives on the affordances and challenges of co‐therapy in psychedelic assisted therapy

open access: yesPsychology and Psychotherapy: Theory, Research and Practice, Volume 99, Issue 4, Page 1604-1626, December 2026.
Abstract Objectives Psychedelic‐assisted therapy (PAT) frequently utilises a “cotherapy” model, in which two therapists jointly support participants throughout dosing and psychotherapy sessions. While common in clinical trials, participant experiences of cotherapy remain underexplored.
Rachel Ham   +3 more
wiley   +1 more source

Psychedelic therapy from an existential psychological viewpoint : a theoretical analysis

open access: yes, 2016
Clinical research into the therapeutic applications of classical psychedelics has slowly but steadily resumed over the last couple of decades. Continuing the research that went dormant in the late 1960‟s, modern trials are looking into the use of high ...
Berg, Stian Hyman
core  

Psychedelic experiences in psychedelic-assisted therapy for depression

open access: yesPhilosophical Psychology
Psychedelics have shown promise as a treatment for depression. Although there is some debate, a popular view is that psychedelics produce their benefits in an experience-dependent manner. This is the view that a depressed person gets better, inter alia, because of the experience she has had on psychedelics.
openaire   +3 more sources

Participant Experiences of Therapeutic Touch in Psilocybin‐Assisted Therapy

open access: yesBrain and Behavior
Introduction Although commonly used in psychedelic‐assisted therapy, the role of therapeutic touch remains loosely defined and ethically sensitive.
Rachel Ham   +3 more
doaj   +1 more source

The Primary Reasons People Participate in Maternal‐Fetal Phase I Clinical Trials Are Psychosocial

open access: yesEthics &Human Research, Volume 48, Issue 6, Page 20-31, November–December 2026.
ABSTRACT Recent critiques of ethical guidance for maternal‐fetal therapy clinical trials has highlighted the need to weigh maternal, fetal, and societal interests, respectively, while deprioritizing psychosocial reasons for participation. Psychosocial reasons refer to the psychological and social influences on study participants’ decisions, and they ...
Julia E. H. Brown   +6 more
wiley   +1 more source

Psychedelic-assisted therapy: A new way forward in mental health

open access: yes, 2019
In the following pages, I will cover many topics relating to psychedelic-assisted therapy. Initially, I explore the historical background of psychedelic use in indigenous communities around the world followed by an introduction of psychedelic-assisted ...
Wibur, Kimberly (Rosie)
core  

Psychedelic Assisted Psychotherapy [PDF]

open access: yes, 2020
Beginning in the early 1900s, research into Psychedelic Assisted Psychotherapy (PAP) showed promising results. After psychedelics were made illegal in the early 1970s they went largely underground.
McDonough, Ross, Ferguson, Lori
core   +1 more source

On Minimizing Risk and Harm in the Use of Psychedelics

open access: yesPsychiatric Research and Clinical Practice
Objective This article outlines recommendations from 30 psychedelic researchers on how to create a better psychedelic safety net. Methods A survey of 30 psychedelic researchers asked them to identify key critical research gaps around psychedelic harm and
Jules Evans   +30 more
doaj   +1 more source

A clinical protocol for group-based ketamine-assisted therapy in a community of practice: the Roots To Thrive model

open access: yesFrontiers in Psychiatry
BackgroundKetamine-assisted therapy (KaT) has demonstrated therapeutic potential in treating depression, anxiety, and PTSD, driving interest in group-based models of care.
Shannon Dames   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy